Nicolas Gendron, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thrombosis | 9 | 2024 | 2956 | 2.110 |
Why?
|
Anticoagulants | 17 | 2024 | 4840 | 2.010 |
Why?
|
Venous Thromboembolism | 7 | 2024 | 1884 | 1.420 |
Why?
|
Factor Xa | 2 | 2024 | 166 | 1.060 |
Why?
|
Thrombophilia | 4 | 2022 | 306 | 1.020 |
Why?
|
Heart, Artificial | 6 | 2022 | 110 | 0.970 |
Why?
|
Drug Monitoring | 5 | 2024 | 964 | 0.930 |
Why?
|
Postthrombotic Syndrome | 1 | 2024 | 28 | 0.910 |
Why?
|
Endothelial Cells | 10 | 2021 | 3586 | 0.900 |
Why?
|
Antidotes | 1 | 2024 | 138 | 0.860 |
Why?
|
Laboratories, Hospital | 1 | 2024 | 192 | 0.840 |
Why?
|
Lupus Coagulation Inhibitor | 2 | 2022 | 32 | 0.820 |
Why?
|
von Willebrand Factor | 8 | 2024 | 679 | 0.750 |
Why?
|
Antithrombins | 3 | 2022 | 294 | 0.680 |
Why?
|
Thiazoles | 2 | 2024 | 1541 | 0.660 |
Why?
|
Venous Thrombosis | 3 | 2024 | 1318 | 0.610 |
Why?
|
Thymoma | 1 | 2019 | 191 | 0.600 |
Why?
|
Anemia, Aplastic | 1 | 2019 | 231 | 0.580 |
Why?
|
Hemorrhage | 4 | 2024 | 3458 | 0.560 |
Why?
|
Blood Coagulation Tests | 5 | 2024 | 271 | 0.560 |
Why?
|
Thymus Neoplasms | 1 | 2019 | 278 | 0.550 |
Why?
|
Hemoglobinuria, Paroxysmal | 1 | 2017 | 96 | 0.550 |
Why?
|
Blood Coagulation | 7 | 2024 | 1162 | 0.550 |
Why?
|
Thromboembolism | 2 | 2021 | 1006 | 0.540 |
Why?
|
Anemia, Hemolytic | 1 | 2017 | 164 | 0.540 |
Why?
|
Administration, Oral | 7 | 2024 | 4041 | 0.510 |
Why?
|
Pyridines | 2 | 2024 | 2888 | 0.480 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3520 | 0.460 |
Why?
|
Endometritis | 1 | 2014 | 49 | 0.460 |
Why?
|
Recombinant Proteins | 1 | 2024 | 6527 | 0.460 |
Why?
|
France | 5 | 2024 | 497 | 0.450 |
Why?
|
Heparin | 5 | 2024 | 1636 | 0.450 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1007 | 0.440 |
Why?
|
Neovascularization, Pathologic | 2 | 2021 | 2643 | 0.440 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2017 | 373 | 0.420 |
Why?
|
Endothelium, Vascular | 6 | 2023 | 4425 | 0.420 |
Why?
|
Streptococcal Infections | 2 | 2014 | 619 | 0.420 |
Why?
|
Bone Marrow | 2 | 2021 | 2929 | 0.410 |
Why?
|
Hematologic Diseases | 1 | 2016 | 499 | 0.400 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2014 | 430 | 0.390 |
Why?
|
Calcinosis | 1 | 2020 | 1485 | 0.390 |
Why?
|
Streptococcus pyogenes | 1 | 2014 | 293 | 0.380 |
Why?
|
von Willebrand Diseases | 2 | 2024 | 134 | 0.380 |
Why?
|
Cell Lineage | 1 | 2020 | 2575 | 0.380 |
Why?
|
Thrombocytopenia | 4 | 2023 | 1183 | 0.380 |
Why?
|
Aortic Valve Stenosis | 2 | 2021 | 2032 | 0.380 |
Why?
|
Hemostasis | 3 | 2023 | 470 | 0.360 |
Why?
|
Aortic Valve | 1 | 2020 | 1968 | 0.360 |
Why?
|
Clinical Laboratory Techniques | 1 | 2016 | 749 | 0.350 |
Why?
|
Antiphospholipid Syndrome | 2 | 2022 | 167 | 0.350 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2014 | 687 | 0.320 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2020 | 520 | 0.320 |
Why?
|
Pain Measurement | 1 | 2019 | 3577 | 0.320 |
Why?
|
Fibrin Fibrinogen Degradation Products | 5 | 2022 | 425 | 0.320 |
Why?
|
Humans | 70 | 2024 | 768451 | 0.310 |
Why?
|
Vascular Diseases | 3 | 2023 | 1162 | 0.300 |
Why?
|
Abortion, Induced | 1 | 2014 | 475 | 0.300 |
Why?
|
Hematologic Neoplasms | 2 | 2019 | 1905 | 0.290 |
Why?
|
Inflammation | 4 | 2023 | 10865 | 0.280 |
Why?
|
Cell Differentiation | 4 | 2020 | 11674 | 0.280 |
Why?
|
Hospital Mortality | 9 | 2023 | 5371 | 0.270 |
Why?
|
Neovascularization, Physiologic | 5 | 2021 | 1369 | 0.260 |
Why?
|
Vitamin K | 2 | 2024 | 314 | 0.240 |
Why?
|
Pain | 1 | 2019 | 5096 | 0.230 |
Why?
|
Factor XI | 1 | 2024 | 34 | 0.230 |
Why?
|
Limit of Detection | 1 | 2024 | 277 | 0.220 |
Why?
|
Cefazolin | 1 | 2023 | 95 | 0.220 |
Why?
|
Heparin, Low-Molecular-Weight | 2 | 2024 | 344 | 0.200 |
Why?
|
Leukocyte L1 Antigen Complex | 1 | 2022 | 94 | 0.200 |
Why?
|
Stem Cells | 5 | 2023 | 3538 | 0.200 |
Why?
|
Factor V | 1 | 2022 | 168 | 0.190 |
Why?
|
alpha 1-Antitrypsin | 1 | 2022 | 169 | 0.190 |
Why?
|
Mice, Nude | 4 | 2020 | 3635 | 0.190 |
Why?
|
Portal Vein | 1 | 2024 | 432 | 0.190 |
Why?
|
Receptors, Interleukin-8A | 1 | 2020 | 47 | 0.180 |
Why?
|
Receptors, Interleukin-8B | 1 | 2020 | 58 | 0.180 |
Why?
|
Pandemics | 5 | 2023 | 8753 | 0.180 |
Why?
|
Injections, Intramuscular | 1 | 2022 | 557 | 0.180 |
Why?
|
Myelopoiesis | 1 | 2021 | 135 | 0.180 |
Why?
|
Drug Interactions | 2 | 2024 | 1421 | 0.170 |
Why?
|
Endocarditis | 1 | 2023 | 355 | 0.160 |
Why?
|
Angiopoietin-2 | 1 | 2020 | 173 | 0.160 |
Why?
|
Toxoplasmosis | 1 | 2019 | 94 | 0.160 |
Why?
|
Paracrine Communication | 1 | 2020 | 278 | 0.160 |
Why?
|
Genetic Variation | 1 | 2014 | 6610 | 0.160 |
Why?
|
Intensive Care Units | 2 | 2021 | 3805 | 0.160 |
Why?
|
Pyridones | 2 | 2024 | 819 | 0.160 |
Why?
|
Immunoglobulin Light Chains | 1 | 2019 | 289 | 0.150 |
Why?
|
Trachea | 1 | 2024 | 1095 | 0.150 |
Why?
|
Aged | 16 | 2024 | 171520 | 0.150 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2020 | 548 | 0.150 |
Why?
|
Endothelium | 1 | 2020 | 768 | 0.150 |
Why?
|
Pulmonary Embolism | 2 | 2022 | 2591 | 0.140 |
Why?
|
Antigens, CD19 | 1 | 2020 | 437 | 0.140 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2020 | 423 | 0.140 |
Why?
|
Valproic Acid | 1 | 2020 | 443 | 0.140 |
Why?
|
Serologic Tests | 1 | 2019 | 383 | 0.140 |
Why?
|
Natriuretic Peptides | 1 | 2018 | 156 | 0.140 |
Why?
|
Male | 26 | 2024 | 364781 | 0.140 |
Why?
|
Aged, 80 and over | 6 | 2021 | 59680 | 0.140 |
Why?
|
Mesoderm | 1 | 2020 | 679 | 0.140 |
Why?
|
Coculture Techniques | 1 | 2020 | 1343 | 0.140 |
Why?
|
Paraproteinemias | 1 | 2019 | 254 | 0.130 |
Why?
|
Cell-Derived Microparticles | 1 | 2018 | 161 | 0.130 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 920 | 0.130 |
Why?
|
Bioprosthesis | 1 | 2020 | 592 | 0.130 |
Why?
|
Middle Aged | 18 | 2024 | 223418 | 0.130 |
Why?
|
Interleukin-8 | 1 | 2019 | 705 | 0.130 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 271 | 0.130 |
Why?
|
Ischemia | 3 | 2021 | 1900 | 0.130 |
Why?
|
Endothelial Growth Factors | 1 | 2018 | 674 | 0.120 |
Why?
|
Interleukin-6 | 2 | 2022 | 3234 | 0.120 |
Why?
|
Blood Vessels | 1 | 2021 | 1112 | 0.120 |
Why?
|
Neprilysin | 1 | 2018 | 487 | 0.120 |
Why?
|
Risk Factors | 6 | 2024 | 74915 | 0.120 |
Why?
|
Blood Cells | 1 | 2016 | 308 | 0.120 |
Why?
|
Abortifacient Agents, Steroidal | 1 | 2014 | 22 | 0.120 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1629 | 0.110 |
Why?
|
Tissue Engineering | 1 | 2024 | 1890 | 0.110 |
Why?
|
Pluripotent Stem Cells | 1 | 2021 | 808 | 0.110 |
Why?
|
Blood Chemical Analysis | 1 | 2016 | 436 | 0.110 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2014 | 65 | 0.110 |
Why?
|
Prognosis | 5 | 2021 | 30028 | 0.110 |
Why?
|
Liver Cirrhosis | 1 | 2024 | 1950 | 0.110 |
Why?
|
Cells, Cultured | 5 | 2020 | 19041 | 0.110 |
Why?
|
Pyrazoles | 2 | 2024 | 2024 | 0.110 |
Why?
|
Secondary Prevention | 1 | 2020 | 1479 | 0.110 |
Why?
|
Osteogenesis | 1 | 2020 | 1296 | 0.110 |
Why?
|
Mammaplasty | 1 | 2023 | 1262 | 0.110 |
Why?
|
Mifepristone | 1 | 2014 | 151 | 0.110 |
Why?
|
Bacteriological Techniques | 1 | 2014 | 277 | 0.110 |
Why?
|
Misoprostol | 1 | 2014 | 94 | 0.110 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.110 |
Why?
|
Female | 21 | 2024 | 396943 | 0.110 |
Why?
|
Protein Multimerization | 3 | 2024 | 980 | 0.100 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 681 | 0.100 |
Why?
|
Culture Media | 1 | 2014 | 899 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2014 | 534 | 0.100 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2017 | 507 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11930 | 0.100 |
Why?
|
Paris | 2 | 2021 | 41 | 0.090 |
Why?
|
Adult | 11 | 2022 | 223542 | 0.090 |
Why?
|
Adipose Tissue | 1 | 2023 | 3335 | 0.090 |
Why?
|
Neoplasms | 1 | 2020 | 22386 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2023 | 2768 | 0.090 |
Why?
|
Cell Separation | 1 | 2016 | 1726 | 0.090 |
Why?
|
Phenotype | 4 | 2020 | 16712 | 0.080 |
Why?
|
Tissue Donors | 1 | 2019 | 2377 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20231 | 0.080 |
Why?
|
E-Selectin | 2 | 2022 | 578 | 0.080 |
Why?
|
Patient Admission | 3 | 2021 | 1370 | 0.080 |
Why?
|
Neoplasm, Residual | 1 | 2014 | 1014 | 0.080 |
Why?
|
Heart Transplantation | 1 | 2022 | 3291 | 0.080 |
Why?
|
Prospective Studies | 5 | 2023 | 54914 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13026 | 0.080 |
Why?
|
Translocation, Genetic | 1 | 2014 | 1395 | 0.080 |
Why?
|
Remission Induction | 1 | 2014 | 2408 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2016 | 1795 | 0.070 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3611 | 0.070 |
Why?
|
Heart Failure | 3 | 2022 | 11857 | 0.070 |
Why?
|
Recurrence | 1 | 2020 | 8510 | 0.070 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2018 | 1482 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12875 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2260 | 0.070 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1671 | 0.070 |
Why?
|
Hindlimb | 2 | 2019 | 516 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 3 | 2021 | 6537 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2020 | 22293 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2024 | 5162 | 0.060 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1855 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4451 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2434 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13708 | 0.060 |
Why?
|
Fetal Blood | 2 | 2021 | 1353 | 0.060 |
Why?
|
Automation, Laboratory | 1 | 2024 | 102 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4285 | 0.060 |
Why?
|
Kidney | 1 | 2019 | 7064 | 0.060 |
Why?
|
Severity of Illness Index | 4 | 2022 | 15965 | 0.050 |
Why?
|
ROC Curve | 2 | 2021 | 3624 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3116 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2024 | 81834 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2181 | 0.050 |
Why?
|
Signal Transduction | 3 | 2020 | 23638 | 0.050 |
Why?
|
Antibodies, Antiphospholipid | 1 | 2022 | 72 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 4984 | 0.050 |
Why?
|
Proportional Hazards Models | 3 | 2021 | 12561 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9791 | 0.050 |
Why?
|
Pyrimidines | 1 | 2014 | 3050 | 0.050 |
Why?
|
Protein C | 1 | 2022 | 134 | 0.050 |
Why?
|
Collagen | 2 | 2021 | 2646 | 0.050 |
Why?
|
Hospitalization | 4 | 2023 | 10845 | 0.050 |
Why?
|
Patients' Rooms | 1 | 2021 | 62 | 0.050 |
Why?
|
Gonadotropins | 1 | 2021 | 241 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39430 | 0.040 |
Why?
|
Thrombomodulin | 1 | 2020 | 107 | 0.040 |
Why?
|
Anastomosis, Surgical | 1 | 2023 | 993 | 0.040 |
Why?
|
Hemolysis | 1 | 2022 | 419 | 0.040 |
Why?
|
Platelet Activation | 1 | 2023 | 646 | 0.040 |
Why?
|
Antigens, CD34 | 1 | 2021 | 656 | 0.040 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2021 | 595 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2832 | 0.040 |
Why?
|
Respiration, Artificial | 2 | 2020 | 2723 | 0.040 |
Why?
|
Molecular Weight | 1 | 2021 | 2173 | 0.040 |
Why?
|
Animals | 5 | 2024 | 169418 | 0.040 |
Why?
|
Troponin I | 1 | 2023 | 662 | 0.040 |
Why?
|
Tachycardia | 1 | 2020 | 599 | 0.040 |
Why?
|
Antibodies, Protozoan | 1 | 2019 | 253 | 0.040 |
Why?
|
Toxoplasma | 1 | 2019 | 159 | 0.040 |
Why?
|
Microsurgery | 1 | 2023 | 803 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2023 | 2126 | 0.040 |
Why?
|
Thrombin | 1 | 2020 | 600 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 787 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 30243 | 0.040 |
Why?
|
Tissue Scaffolds | 1 | 2024 | 948 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2023 | 1097 | 0.040 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2019 | 179 | 0.040 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2018 | 325 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 350 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5223 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1640 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1738 | 0.030 |
Why?
|
Mice | 2 | 2020 | 82045 | 0.030 |
Why?
|
Myofibroblasts | 1 | 2018 | 232 | 0.030 |
Why?
|
Adipocytes | 1 | 2023 | 1199 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26351 | 0.030 |
Why?
|
Systole | 1 | 2018 | 938 | 0.030 |
Why?
|
Chondrogenesis | 1 | 2017 | 239 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1532 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2021 | 1021 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 60045 | 0.030 |
Why?
|
Adipogenesis | 1 | 2017 | 370 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5996 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2017 | 1502 | 0.030 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1249 | 0.030 |
Why?
|
Chest Pain | 1 | 2020 | 1099 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1066 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1518 | 0.030 |
Why?
|
Prevalence | 2 | 2020 | 15880 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1833 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1621 | 0.030 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 506 | 0.030 |
Why?
|
Lung | 2 | 2022 | 10090 | 0.020 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1602 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3103 | 0.020 |
Why?
|
Testosterone | 1 | 2021 | 2493 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8730 | 0.020 |
Why?
|
Pregnant Women | 1 | 2014 | 576 | 0.020 |
Why?
|
Transfection | 1 | 2017 | 5767 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2018 | 1751 | 0.020 |
Why?
|
Homeostasis | 1 | 2020 | 3351 | 0.020 |
Why?
|
Vagina | 1 | 2014 | 845 | 0.020 |
Why?
|
Protein Binding | 1 | 2021 | 9376 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8559 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7449 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4180 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5904 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2717 | 0.020 |
Why?
|
Cohort Studies | 1 | 2019 | 41797 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20762 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2994 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 30179 | 0.020 |
Why?
|
Proteomics | 1 | 2020 | 3901 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13655 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2018 | 5152 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2021 | 7895 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10494 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2020 | 9507 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4877 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12813 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15460 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24311 | 0.010 |
Why?
|
MicroRNAs | 1 | 2018 | 3805 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 26395 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14728 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36497 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42623 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18388 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65409 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40271 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 12242 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15638 | 0.010 |
Why?
|
Child | 1 | 2021 | 80863 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89168 | 0.010 |
Why?
|